Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Could This Be Eli Lilly's Next Blockbuster Drug?
Could This Be Eli Lilly's Next Blockbuster Drug?
Could This Be Eli Lilly's Next Blockbuster Drug?
Submitted by
admin
on March 20, 2022 - 11:01pm
Source:
Motley Fool
News Tags:
Eli Lilly
mirikizumab
ulcerative colitis
Headline:
Could This Be Eli Lilly's Next Blockbuster Drug?
snippet:
Mirikizumab could be used by tens of thousands of patients if approved by the U.S. Food and Drug Administration.
An ulcerative colitis indication could generate $800 million in annual sales for Eli Lilly in the U.S. alone.
Eli Lilly still looks like it could be a buy for growth investors.
Do Not Allow Advertisers to Use My Personal information